Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice

Price changes

New co-payments, subsidies and drug prices that affect our comparisons — each with an official source and date.

Subscribe via RSS

  1. upcoming from January 1, 2027

    Germany: fixed dental subsidy falls to 50/60/65%

    For treatment plans approved from January 1, 2027, statutory insurance pays 50% of the standard-care amount, 60% or 65% with a five- or ten-year check-up record — down from 60/70/75%. Plans approved earlier keep the old rates; hardship cases still get the full standard-care amount.

    Affects: Dental implants · All-on-4 · Crowns

    Source: Bundesgesetzblatt 2026 I Nr. 228 (GKV-Beitragssatzstabilisierungsgesetz), Art. 1 Nr. 22/23, Art. 8 Abs. 2

  2. upcoming from January 1, 2027

    Medicare negotiated price for semaglutide takes effect

    From January 1, 2027, Medicare's negotiated price for semaglutide (Ozempic, Rybelsus, Wegovy) applies: $274 for a 30-day supply, 71% below the 2024 list price; $385.63 for a Wegovy pack of four 2.4 mg pens.

    Affects: Ozempic · Wegovy & Zepbound

    Source: CMS — Negotiated prices for initial price applicability year 2027 (fact sheet)

  3. upcoming from January 1, 2027

    US list price of Ozempic and Wegovy falls to $675

    Novo Nordisk announced that the US list price of Ozempic, Wegovy and Rybelsus falls to $675 a month for all doses from January 1, 2027 — about 35% lower for Ozempic.

    Affects: Ozempic · Wegovy & Zepbound

    Source: Novo Nordisk, Pressemitteilung / press release, 24.2.2026

  4. upcoming from January 1, 2027

    Germany: prescription co-payment rises to €7.50–€15

    From January 1, 2027, people with statutory insurance in Germany pay 10% of the price per pack, at least €7.50 and at most €15 — up from €5–€10; never more than the price itself.

    Affects: EpiPen · Insulin · Inhaler

    Source: Bundesgesetzblatt 2026 I Nr. 228 (GKV-Beitragssatzstabilisierungsgesetz), Art. 1 Nr. 22/23, Art. 8 Abs. 2

  5. upcoming from January 1, 2027

    Germany: hospital co-payment rises to €15 a day

    From January 1, 2027, the co-payment for an inpatient hospital stay is €15 per calendar day instead of €10, still for at most 28 days a year — up to €420 instead of €280.

    Affects: Knee replacement · Hip replacement · Spinal fusion

    Source: Bundesgesetzblatt 2026 I Nr. 228 (GKV-Beitragssatzstabilisierungsgesetz), Art. 1 Nr. 22/23, Art. 8 Abs. 2

  6. in effect since July 1, 2026

    Medicare: $50 copay for weight-loss GLP-1s (temporary)

    Since July 1, 2026, Medicare enrollees pay a $50 copay for certain weight-loss GLP-1 drugs (Wegovy, Zepbound KwikPen, Foundayo) — a temporary program running through December 31, 2027.

    Affects: Wegovy & Zepbound · Mounjaro

    Source: CMS — Medicare GLP-1 Bridge

Cost information, not legal or medical advice. As of October 26, 2026.